SPEVIGO
SPEVIGO
Approved
DIN Number
02536455
Drug Class
Human
Market Date
May 11, 2023
Company
HC
boehringer ingelheim (canada) ltd ltee
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02536455
AIG Number0164521001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AC22 SPESOLIMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification84:06.28
Health Canada Classification
ACTIVE INGREDIENTS (1)
SPESOLIMABActive
Strength: 60 MG / ML
Monograph: SPESOLIMAB